LYRFIGTU FDA approval date

The FDA approved LYRFIGTU on 23 Sep 2026.

FDA approval date
23 Sep 2026

Drug identity has not yet been verified against registry records

Also recorded as LIRAFUGRATINIB HYDROCHLORIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2026-09-23DayLYRFIGTUFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA220425", "applicant_as_listed_by_fda": "ELEVAR THERAPEUTICS INC", "brand_names": ["LYRFIGTU"], "active_ingredients": ["LIRAFUGRATINIB HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20260923", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026